comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 22:40:43 - browse：261

President Joe Biden speaks at a campaign event at Pullman Yards on March 9, 2024 in Atlanta, Georgia. — President Biden speaks at a campaign event in Atlanta this month. Megan Varner/Getty Images

WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his last chance to cement a legacy on drug costs, cancer research, and broad health care coverage.

The president’s $130.7 billion proposal is a dip from the $144.3 billion requested for this financial year and a nod to the tough line Congress has taken on government spending.

Biden also designed the plan to grab the attention of voters. While presidential budget proposals always include a long list of priorities that are unlikely to become law, Biden’s budget aims to show voters what they’d get in return for keeping him in office and voting in a Democratic-controlled Congress, including lower health care costs, expanded insurance coverage, and beefed up cybersecurity for hospitals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Feng Zhang, Grail founder join forces on new gene editing startup

explore

WSS

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

J&J to buy cancer drug developer Ambrx Biopharma

Why psychiatrists like me stop taking insurance

SAMSHA loosens regulations on methadone treatment centers

Cybersecurity threat forces Lurie Children's to take systems offline

Congressmen charge Covid hearing ‘could have been an email’

Wikipedia

comprehensive

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Do digital therapeutics have a future in medicine?

After affirmative action ruling, medical educators look to 'holistic review'

Morgan Health, with ambitious aims, wants you to know it’s still here

State Dept. review finds Biden bears some blame for Afghanistan failures

A $475,000 price tag for a new cancer drug: crazy or meh?

Drug repurposing or repositioning? The language matters

Vertex non

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ARCH Venture Partners is raising $3 billion for a life sciences fund

explore

Antibiotic resistance and the global rise in human conflict

The real point of Kenneth Smith’s execution by nitrogen gas

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Covid misinformation case heads to Supreme Court

Cognito secures funding to test medical device for Alzheimer's

Do digital therapeutics have a future in medicine?

explore

knowledge

Wikipedia

focus